Initial discussion with patient to outline full treatment pathway of chemoradiation and immunotherapy.
Opportunity to counsel patients on immunotherapy prior to the initiation of immunotherapy.
During follow-up visits, reinforce the benefit of treatment continuation with immunotherapy to ensure patients complete the treatment course.